Prokidney (PROK) Gains from Sales and Divestitures (2022 - 2026)

Prokidney (PROK) has 5 years of Gains from Sales and Divestitures data on file, last reported at $723163.0 in Q1 2026.

• Gains from Sales and Divestitures for Q1 2026 came in at $723163.0, down 23.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $723163.0 (down 23.85% YoY), and the FY2025 annual result was $959764.0, down 28.19% from the prior year.
• Gains from Sales and Divestitures declined to $723163.0 in Q1 2026 per PROK's latest filing, from $959764.0 in the prior quarter.
• Over five years, Gains from Sales and Divestitures peaked at $2.3 million in Q3 2023 and troughed at $723163.0 in Q1 2026.
• A 5-year average of $1.4 million and a median of $1.3 million in 2024 frame the typical range for Gains from Sales and Divestitures.
• The sharpest annual moves came in 2023 and 2024: Gains from Sales and Divestitures soared 65.89% in 2023, then sank 41.55% in 2024.
• A 5-year view of Gains from Sales and Divestitures shows it stood at $1.7 million in 2022, then soared by 30.67% to $2.3 million in 2023, then sank by 41.02% to $1.3 million in 2024, then fell by 28.19% to $959764.0 in 2025, then dropped by 24.65% to $723163.0 in 2026.
• Business Quant data shows PROK's Gains from Sales and Divestitures at $723163.0 in Q1 2026, $959764.0 in Q4 2025, and $959764.0 in Q3 2025.